PharmaLundensis Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Staffan Skogvall
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 18.3yrs |
| CEO ownership | 50.7% |
| Management average tenure | no data |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
CEO
Staffan Skogvall (60 yo)
18.3yrs
Tenure
Dr. Staffan Skogvall founded PharmaLundensis AB in 2006 and since then serves as its Chief Executive Officer and Director. Dr. Skogvall holds Dissertation in Lung Physiology 1999 at Lund University with “R...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 18.3yrs | no data | 50.68% SEK 7.7m | |
| Chairman of the Board | 3.8yrs | no data | 0.52% SEK 79.2k | |
| Director | 3.8yrs | no data | no data | |
| Director | 3.8yrs | no data | no data | |
| Director | 3.3yrs | no data | no data |
3.8yrs
Average Tenure
72yo
Average Age
Experienced Board: PHAL's board of directors are considered experienced (3.8 years average tenure).